Glaukos Corporation - Search Videos

Glaukos Corporation : Opinion positive de Truist Securities

Glaukos Corporation : Opinion positive de Truist Securities

Glaukos Corporation | LinkedIn

Glaukos Corporation | LinkedIn

Glaukos Corporation Reaffirms Revenue Guidance for 2025

Glaukos Corporation Reaffirms Revenue Guidance for 2025

marketscreener.com

Glaukos by _Code

Glaukos by _Code

Glaukos International - Eyetube

Glaukos International - Eyetube

Earnings Flash (GKOS) Glaukos Corporation Posts Q4 Adjusted Loss $0.28 per Share, vs. FactSet Est of $-0.20

Earnings Flash (GKOS) Glaukos Corporation Posts Q4 Adjusted Loss $0.28 per Share, vs. FactSet Est of $-0.20

marketscreener.com

Paul Singh, MD, discusses the changing paradigm for glaucoma treatment, highlighting how MIGS devices, like the iStent inject W, help address a previously unmet need for mild-to-moderate #glaucoma patients. Watch the full series on Eyetube. https://bit.ly/3sPmwj4 | Eyetube

Paul Singh, MD, discusses the changing paradigm for glaucoma treatment, highlighting how MIGS devices, like the iStent inject W, help address a previously unmet need for mild-to-moderate #glaucoma patients. Watch the full series on Eyetube. https://bit.ly/3sPmwj4 | Eyetube

38 viewsNov 2, 2022

FacebookEyetube

Enriching the lives and treatments of patients across the world | Glaukos Corporation

iAccess Trabecular Trephine - Eyetube

Glaukos Corporation has received U.S. regulatory approval from the FDA for Epioxa HD (riboflavin 5’-phosphate ophthalmic solution) / Epioxa (riboflavin 5’-phosphate ophthalmic solution) 0.177%, a corneal collagen crosslinking (CXL) iLink therapy. The long-anticipated announcement is right on schedule after the company’s February 2025 new drug application (NDA) submission. How exciting! Start with the basics of this. Epioxa (pronounced E pee ox’ ah) is the latest iteration of Glaukos’s corneal CX

5.6K views2 months ago

Facebook2020 Glance

Here is What Hedge Funds Think About Glaukos Corporation (GKOS)

insidermonkey.com

Glaukos bringing more than 150 jobs to Cummings Research Park

Glaukos is committed to addressing the greatest unmet needs in eye care. Since 2018, we've invested $700 million in R&D to develop a pipeline of novel therapies. Our unrivaled portfolio is transforming treatments in glaucoma, corneal health, and retinal disease. Learn more: https://bit.ly/47FsOaj | Glaukos

141.3K views5 months ago

FacebookGlaukos

FDA approval for progressive keratoconus

The Rise of Interventional Glaucoma: Prof. Tina Wong on Surgical Freedom with Glaukos’ iStent®

YouTubeMedia MICE

Glaukos 10 Years in Australia: 3 Million Implants Worldwide & The Future of Glaucoma Care!

YouTubeThe Innovation Science Hub

8.2K views2 months ago

Glaukos Perfume Release by Prime Monkeys

2.2K views2 months ago

TikTokbdjsbxjsnx

GLAUKOS vs SILVER EDGE: Which is Better?

2K views2 months ago

TikTokbdjsbxjsnx

Glaukos: Prime Monkey Official Release Announcement

1.5K views2 months ago

TikTokalmieren15

The Rise of Interventional Glaucoma: Dr. Prin Rojanapongpun on Efficiency with Glaukos’ iStent® | Media MICE

greekmythology.com

CPC for Glaucoma Treatment

13.1K viewsMar 26, 2018

YouTubeEyeSmart — American Academy of Ophthalmo…

Glaukos iStent

9.5K viewsMar 12, 2015

YouTubeEyes Arizona

iStent Inject by Glaukos

6.2K viewsJul 29, 2016

How to File a Company CT600 Corporation Tax return to HMRC online

143.5K viewsJun 25, 2020

YouTubeEasy Digital

iStent inject Trabecular Bypass (Procedure Animation)

9.9K viewsAug 17, 2018

YouTubeGlaukos Corporation

Understanding Glaucoma Diagnosis, Treatment, and Research on the Horizon

21.5K viewsAug 15, 2021

YouTubeUniversity of California Television (UCTV)

Combined cataract surgery with iStent Inject W ("Wide") glaucoma device implantation

748 viewsMay 11, 2021

YouTubeDr Sami A. Saad

"3 Waters Big Fish 120" Fishing Kayak REVIEW!!

31.5K viewsOct 1, 2019

YouTubeA & T Tech Outdoors

See more